Eventide Asset Management - CIDARA THERAPEUTICS INC ownership

CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 54 filers reported holding CIDARA THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of CIDARA THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$1,170,000
-45.3%
172,000
-34.8%
0.06%
-49.6%
Q3 2017$2,138,000
+8.0%
264,0000.0%0.12%
-1.6%
Q2 2017$1,980,000
-3.8%
264,0000.0%0.12%
-9.6%
Q1 2017$2,059,000
-25.0%
264,0000.0%0.14%
-24.0%
Q4 2016$2,746,000
-9.2%
264,0000.0%0.18%
-3.2%
Q3 2016$3,023,000
+11.1%
264,0000.0%0.18%
+10.8%
Q2 2016$2,722,000
-18.8%
264,0000.0%0.17%
-10.7%
Q1 2016$3,353,000
-26.0%
264,0000.0%0.19%
-17.3%
Q4 2015$4,530,000
+103.0%
264,000
+50.5%
0.23%
+73.8%
Q3 2015$2,231,000
+29.8%
175,400
+43.0%
0.13%
+39.8%
Q2 2015$1,719,000122,6280.09%
Other shareholders
CIDARA THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 1,627,670$1,533,5911.88%
5AM Venture Management, LLC 1,134,511$1,068,9360.31%
Nantahala Capital Management 2,538,406$2,391,6860.20%
BVF INC/IL 6,861,127$6,464,5540.17%
Monashee Investment Management LLC 369,099$347,7650.14%
West Family Investments, Inc. 368,910$347,5870.12%
JEPPSON WEALTH MANAGEMENT, LLC 137,560$129,6090.06%
XTX Topco Ltd 202,758$191,0390.03%
GSA CAPITAL PARTNERS LLP 136,974$1290.01%
Callan Capital, LLC 103,462$97,4820.01%
View complete list of CIDARA THERAPEUTICS INC shareholders